Broadwater Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.46K Hold
75
﹤0.01% 169
2026
Q1
$6.74K Hold
75
0.01% 169
2025
Q4
$6.74K Sell
75
-202
-73% -$19.2K 0.01% 169
2025
Q3
$27.3K Sell
277
-24,965
-99% -$2.47M 0.02% 122
2025
Q2
$25.2M Buy
25,242
+24,890
+7,071% +$2.41M 0.02% 124
2025
Q1
$39.8K Hold
352
0.03% 116
2024
Q4
$37.2K Hold
352
0.03% 119
2024
Q3
$38K Hold
352
0.03% 125
2024
Q2
$38.2K Hold
352
0.03% 125
2024
Q1
$46.4K Hold
352
0.04% 120
2023
Q4
$42.8K Buy
+352
New +$39.3K 0.03% 122

Other funds holding ZBH

Broadwater Capital's ZBH Position: Q2 2026 in Review

Broadwater Capital held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 75 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #169.

Broadwater Capital first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $25.2M in Q2 2025. 430 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Broadwater Capital held 75 shares of Zimmer Biomet worth $6.46K as of Q2 2026.
  • Broadwater Capital left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Broadwater Capital's portfolio in Q2 2026, its #169 holding.
  • Broadwater Capital first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • Broadwater Capital's Zimmer Biomet position peaked at $25.2M in Q2 2025.
  • 430 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.